MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial
- Alexander T. Pearson
- Jameel Muzaffar
- Kedar Kirtane
- Emily Bellile
- Krithika Suresh
- Ari J. Rosenberg
- Francis Worden
- Christine H. Chung
- Everett Vokes
- J. Chad Brenner
- Apurva Bhangale
- Jon McHugh
- Kristy Warner
- Felipe Nor
- Jacques E. Nor
- Keri Innes
- Yifan Zhai
- Tommy Fu
- Paul L. Swiecicki
2026-03-19